is there an fda approved oral glp 1 US accepts Novo Nordisk's application for Wegovy for weight loss FDA Approves First-Of-Its-Kind Oral GLP-1

This is the most common issue for men over 40

This makes it particularly well suited to patients who value facial softness and volume, while still wanting measurable lifting, tightening and improvement in skin texture

It may also appeal to patients who want predictable monthly pricing instead of waiting for uncertain coverage decisions

Does efficacy decline over time (tachyphylaxis)

Commonly reported side effects in the Phase 2 trial included: Nausea (the most frequently reported adverse effect) Vomiting Diarrhoea Constipation Decreased appetite Abdominal discomfort or bloating Eructation (belching) The majority of participants who discontinued treatment did so due to gastrointestinal side effects, underscoring the importance of the slow titration schedule used in trials